期刊文献+

帕金森病患者行下腹或下肢手术全麻苏醒质量及认知功能的变化 被引量:8

To investigate the emergence quality and cognitive function in Parkinson's patients undergoing lower abdomen or legs surgery with general anesthesia
下载PDF
导出
摘要 目的观察帕金森病患者行下腹或下肢手术全麻苏醒苏醒质量及认知功能的变化。方法选择择期在全身麻醉下行下腹或下肢手术的帕金森病患者26例(PD组)和在全身麻醉下行下腹或下肢手术的无帕金森病病史患者26例(NP组),于术前1d采用简易精神状态量表(MMSE)对认知功能评分。两组均使用咪达唑仑、芬太尼、顺阿曲库铵、丙泊酚行麻醉诱导,术中丙泊酚以5mg·kg-1·h-1和瑞芬太尼6μg·kg-1·h-1为起始输注速度,并根据BIS和MAP调节两种麻醉药物输注速度维持适宜麻醉深度,记录低血压发生次数和升压药物用量。术毕停止丙泊酚和瑞芬太尼的输注,观察并记录首次睁眼时间、拔管时间、达OAA/S评分5分时所需时间及术后24h的MMSE评分。结果 NP组术中瑞芬太尼和丙泊酚用量明显多于PD组(P<0.05),NP组血压下降次数和去氧肾上腺素用量明显少于PD组(P<0.05);NP组的首次睁眼时间、拔管时间、达OAA/S评分5分时所需时间明显短于PD组(P<0.05);NP组术后24h的MMSE评分明显高于PD组(P<0.05)。多元线性回归分析显示:帕金森病(β=0.513,t=3.350,P<0.05)是影响达到OAA/S 5分所需时间的显著预测变量(R2=0.256,回归模型F=3.163,P<0.05)。其余因素均为不显著的预测变量。帕金森病(β=0.468,t=3.203,P<0.05)也是影响术后24h MMSE评分的显著预测变量(R2=0.325,回归模型F=4.430,P<0.05)。其余因素均为不显著的预测变量。结论帕金森病患者较非帕金森病患者的全身麻醉苏醒时间延长,术后24h认知功能显著低于非帕金森病患者。 Objective To investigate the emergence quality and cognitive function in Parkinson's patients undergoing general anesthesia. Methods Twenty-six Parkinson's patients(group PD)and twenty-six non-Parkinson's patients(group NP)undergoing selective lower abdominal or lower extremity surgery in general anesthesia were enrolled in the study.Their cognitive functions were assessed one day before operative with Mini-Mental State Examination(MMSE).Both groups received anesthesia induction with midazolam,fentanyl,cis-atracurium and propofol.Intraoperative anesthesia was maintained with propofol(5 mg · kg-1· h-1)and remifentanil(6μg·kg^-1·h^-1).The anesthetic infusion rate was adjusted according to bispectral index(BIS)value and mean arterial pressure(MAP)in order to maintain appropriate anesthesia depth.The frequency of hypotension and dosage of vessel pressor agent were recorded.The infusion of propofol and remifentanil were stopped at the end of the surgery.The time to eyes-open,extubation time,time when OAA/S score to 5,and MMSE score 24 hours postoperatively were recorded and compared.Results The time to eyes-open,extubation time,and time when OAA/S score to 5in group PD were longer than those in group NP(P〈0.05).Postoperative MMSE score in group PD was significantly lower than that in group NP(P〈0.05).Multiple linear regression analysis revealed that Parkinson's disease was a significant predictive variable affecting sedative score and postoperative 24 hour MMSE score,with R2 of 0.256 and 0.325,respectively(P〈0.05).Conclusion Parkinson's patients have longer emergence time and worse cognitive function than non-Parkinson's after general anesthesia.
出处 《临床麻醉学杂志》 CAS CSCD 北大核心 2015年第5期472-475,共4页 Journal of Clinical Anesthesiology
关键词 帕金森病 苏醒时间 全身麻醉 认知功能 Parkinson's disease Awakening time General anesthesia Cognitive function
  • 相关文献

参考文献9

  • 1Wiklund A, Granon S, Faure P, et al. Object memory in young and aged mice after sevoflurane anaesthesia. Neurore- port, 2009,20(16) : 1419-1423.
  • 2詹中利.麻黄碱致帕金森病严重高血压反应一例[J].内蒙古医学杂志,2010,42(4):492-492. 被引量:4
  • 3唐红梅,张玉虎,王丽娟.脑白质损害与帕金森病认知功能障碍的研究进展[J].中华老年心脑血管病杂志,2014,16(3):327-329. 被引量:23
  • 4Rasmussen LS, Johnson T, Kuipers HM, et al. Does anaes- thesia cause postoperative cognitive dysfunction? A random- ised study of regional versus general anaesthesia in 438 elder- ly patients. Acta anaesthesiologica Scandinavica, 2003, 47 (3) :260-266.
  • 5文雯,迟猛,王国年.术后谵妄与神经递质[J].临床麻醉学杂志,2014,30(10):1037-1040. 被引量:17
  • 6Isaacson SH, Skettini J. Neurogenic orthestatic hypotension in Parkinson's disease: evaluation, mananent, and emerging role of droxidopa. Vasc Health Manag, 2014,10..169-176.
  • 7Pereira JB, Svenningsson P, Weintraub D, et al. Initial cog- nitive decline is associated with cortical thinning in early Par- kinson disease. Neurology, 2014,82(22) ~ 2017-2025.
  • 8王春光,瞿慧,艾青,张志捷,段满林,徐建国.舒芬太尼、曲马多对雷米芬太尼苏醒期躁动的预防效应[J].临床麻醉学杂志,2007,23(11):897-900. 被引量:92
  • 9Nakajima R, Kato J, Iwasaki K, et al. Effects of the induc- tion of anesthesia with propofol on hemodynamles in patients with Parkinson's disease. Masui. The Japanese journal of an- esthesiology, 2011,60(10) : 1135-1143.

二级参考文献37

  • 1刘利新.双腋下非霍奇金淋巴瘤1例[J].中国误诊学杂志,2007,7(2):411-411. 被引量:4
  • 2Glass PSA, Sharer SL, Reves JG. Intravenous drug delivery system. In: Miller RD, eds. Anesthesia. 5th ed. New York: Churchill Livingstone, 2001. 377-411.
  • 3Campistol JM, Sacks SH. Mechanisms of nephrotoxicity. Transplantation, 2000, 69 : SS5-10.
  • 4Dennis MJ, Foster MC, Ryan J J, et al. The increasing importance of chronic rejection as a cause of renal allograft failure. Transpl Int,1989, 2:214-217.
  • 5Derrode N, Lebrun F, Levron JC, et al. Influence of preoperative opioid on postoperative pain after major abdominal surgery, sufentanil TCI versus remifentanil TCI. A randomized, con- trolled study. Br J Anaesth,2003, 91: 842-849.
  • 6Hansen EG, Duedahl TH, Romsing J, et al. Intra-operative remifentanil might influence pain levels in the immediate post- operative period after major abdominal surgery. Acta Anaesthesiol Scand, 2005,49 : 1464-1470.
  • 7Koppert W, Angst M, Alsheimer M, et al. Naloxone provokes similar pain facilitation as observed after short-term infusion of remifentanil in humans. Pain, 2003,106 : 91-99.
  • 8Angst MS, Koppert W, Pahl I, et al. Short-term infusion of the mu-opioid agonist remifentanil in humans causes hyperalgesia during withdrawal. Pain, 2003,106 : 49-57.
  • 9Kochs E, Cote D, Deruyck L, et al. Postoperative pain management and recovery after remifentanil-based anaesthesia with isoflurane or propofol for major abdominal surgery. Br J Anaesth, 2000, 84:169-173.
  • 10Guntz E, Herman P, Debizet E, et al. Effects of remifentanil on N-methyl-D-aspartate receptor: an electrophysiologic study in rat spinal cord. Anesthesiology, 2005,102 : 1235-1241.

共引文献131

同被引文献79

  • 1白雪松,金辉,黄学洙.Klotho蛋白与老年人术后认知功能障碍的关系[J].中国老年学杂志,2015,35(1):3-4. 被引量:8
  • 2张振馨.帕金森病的诊断[J].中华神经科杂志,2006,39(6):408-409. 被引量:616
  • 3Broen MP, Braaksma MM, Patijn J, et al. Prevalence of painin Parkinsoris disease: a systematic review using the modifiedQUADAS tool. Mov Disord,2012,27(4) : 480-484.
  • 4Nolano M, Provitera V. Estraneo A, et al. Sensory deficit inParkinson*s disease: evidence of a cutaneous denervation.Brain, 2008,131 (Pt 7): 1903-1911.
  • 5Mylius V. Brebbermann J, Dohmann H, et al. Pain sensitiv-ity and clinical progression in Parkinson's disease. Mov Dis-ord, 2011, 26(12): 2220-2225.
  • 6Tinazzi M, Del Vesco C,Defazio G, et al. Abnormal pro-cessing of the nociceptive input in Parkinson^ disease : a studywith C02 laser evoked potentials. Pain, 2008, 136 (1-2):117-124.
  • 7Del Tredicik,Rub U,De Vos RA, et al. Where does parkin-son disease pathology begin in the brain. J Neuropathol ExpNeurol,2002, 61(5): 413-426.
  • 8Melse M,Tan SK, Temel Y,et al. Changes in 5-HT2A re-ceptor expression in untreated, de novo patients with Parkin-son's disease. J Parkinsons Dis, 2014,4(2):283-287.
  • 9HALLIDAY G M, LEVERENZ J B, SCHNEIDER J S, et al. The neurobiological basis of cognitive impairment in Parkinson's disease[J]. Mov Disord, 2014, 29(5) : 634-650.
  • 10GONZALEZ-REDONDO R, GARCIA-GARCIA D, CLAVERO P, et al. Grey matter hypometabolism and atrophy in Parkinson's disease with cognitive impairment: a two-step proeess[J]. Brain, 2014, 137(Pt 8): 2356-2367.

引证文献8

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部